Transdermal delivery of imipramine hydrochloride: Development and evaluation (in vitro and in vivo) of reservoir gel formulation

Biopharmaceutics and Drug Disposition

Volumn 26, Issue 2, 2005, Pages 41-49

  Jain, Amit Kumar ^a,b   Panchagnula, Ramesh ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b University of California   (United States)

Author keywords

Menthol and oleic acid; Pharmacokinetics; Reservoir patch; Tricyclic antidepressants

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; IMIPRAMINE; MENTHOL; OLEIC ACID; PENETRATION ENHANCING AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG FORMULATION; DRUG PACKAGING; DRUG SAFETY; DRUG SCREENING; DRUG STABILITY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MALE; MEAN RESIDENCE TIME; NONHUMAN; PLASMA VISCOSITY; RAT; SKIN PENETRATION; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; AREA UNDER CURVE; DRUG EVALUATION, PRECLINICAL; DRUG STABILITY; FEMALE; GELS; HUMANS; IMIPRAMINE; MALE; MENTHOL; OLEIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SOLUBILITY;

EID: 15544385466     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdd.428     Document Type: Article

References (13)

1. Stimmel GL. Mood disorders. In Textbook of Therapeutics, Drug and Disease Management, Herfindal ET, Gourley DR (eds). William and Wilkins: Philadelphia, 1996; 1095-1116.
2. Berner B, John VA. Pharmacokinetic charcterization of transdermal delivery systems. Clin Pharmacokinet 1994; 26: 121-134.
3. Panchagnula R. Transdermal drug delivery of tricyclic antidepressants: feasibility study. STP Pharm Sci 1996; 6: 441-444.
4. Stott PW, Williams AC, Barry BW. Characterization of complex coacervates of some tricyclic antidepressants and evaluation of their potential for enhancing transdermal flux. J Control Release 1996; 41: 215-227.
5. Jain AK, Thomas NS, Panchagnula R. Transdermal delivery tricyclic antidepressants I: effect of terpenes. J Control Release 2002; 79: 93-101.
6. Jain AK, Panchagnula R. Transdermal delivery tricyclic antidepressants: effect of fatty acids. Methods Find Exp Clin Pharmacol 2003; 25: 413-421.
7. Jain AK, Panchagnula R. Combination strategy of penetration enhancement for transdermal delivery: studies with imipramine hydrochloride. Pharmind®-die Pharmazeutische Industrie 2004; 66 478-482.
8. Alexander P. Organic rheological additives. Manu Chemist 1986; Oct: 81-4.
9. Gandhi R, Sharma P, Chawla HPS, Kaul CL, Panchagnula R. HPLC analysis of tricyclic antidepressants (TCAs) in skin diffusion studies. STP Pharm Sci 2000; 10: 234-238.
10. Viegas TX, Hikal AH, Jones AB. Percutaneous absorption of bendroflumethiazide from gel and membrane-controlled gel systems: an in vitro study and in vivo study. Int J Pharm 1997; 152 165-178.
11. Williams AC, Barry BW. Terpenes, the lipid-protein-partitioning theory of skin penetration enhancement. Pharm Res 1991; 8: 17-24.
12. Takayama K, Nagai T. Simultaneous optimization for several characteristics concerning percutaneous absorption, skin damage of ketoprofen hydrogels containing D-limonene. Int J Pharm 1991; 74 115-126.
13. Nicolettos NI, Taft DR, Bellantone RA, Plakogiannis FM. Transdermal delivery of tricyclic antidepressants. Pharm Manu Rev 1999; Oct: 22-23.